Navigating the research price landscape for combined growth hormone secretagogues requires a deep understanding of analytical validation, peptide synthesis chemistry, and batch purity standards. The combination of CJC-1295 (No DAC) and Ipamorelin represents one of the most widely evaluated dual-acting research complexes in endocrine and tissue repair literature. PX1 Research supplies high-purity, US-manufactured research peptides designed strictly for in vitro and laboratory research applications.
Navigating the research price landscape for combined growth hormone secretagogues requires a deep understanding of analytical validation, peptide synthesis chemistry, and batch purity standards. The combination of CJC-1295 (No DAC) and Ipamorelin represents one of the most widely evaluated dual-acting research complexes in endocrine and tissue repair literature. PX1 Research supplies high-purity, US-manufactured research peptides designed strictly for in vitro and laboratory research applications.
The research price for a CJC-1295 (No DAC) and Ipamorelin blend reflects the underlying costs of solid-phase peptide synthesis (SPPS), multi-step reverse-phase HPLC purification, and quantitative analytical verification. High-purity laboratory formulations generally range in cost based on total milligram mass, batch size, independent third-party certification parameters, and specific lot endotoxin thresholds.
When procurement departments evaluate vendor pricing, value is determined by structural integrity and analytical documentation rather than retail markups. Premium research compounds from PX1 Research undergo complete high-performance liquid chromatography (HPLC) and mass spectrometry (MS) characterization to ensure identity, purity, and low endotoxin burdens suitable for rigorous preclinical protocols.
CJC-1295 without Drug Affinity Complex (No DAC)—chemically classified as Modified GRF 1-29—is a 29-amino acid synthetic peptide analog of endogenous Growth Hormone-Releasing Hormone (GHRH). By substituting specific amino acids at positions 2, 8, 15, and 27, researchers increased metabolic stability against enzymatic cleavage by dipeptidyl peptidase IV (DPP-IV) while retaining selective affinity for the GHRH receptor.
Ipamorelin is a synthetic pentapeptide (Aib-His-D-2-Nal-D-Phe-Lys-NH2) functioning as a selective ghrelin receptor agonist, or growth hormone secretagogue receptor (GHS-R1a) ligand. Unlike earlier growth hormone-releasing peptides (GHRPs), Ipamorelin does not significantly trigger secondary neuroendocrine pathways, demonstrating high selectivity in preclinical assays without elevating baseline plasma cortisol or prolactin concentrations.
When paired, these two distinct molecular classes engage separate membrane receptors on pituitary somatotropes. In vitro data indicate that co-activation of the GHRH receptor via CJC-1295 (No DAC) and the GHS-R1a receptor via Ipamorelin produces a synergistic intracellular signaling cascade, magnifying physiological growth hormone release compared to isolated peptide exposure.
Preclinical studies evaluate CJC-1295 (No DAC) combined with Ipamorelin to observe real-time somatotrope response curves, pulsatile GH release, and downstream Insulin-like Growth Factor 1 (IGF-1) transcription. Because CJC-1295 (No DAC) lacks the maleimido-propionic acid linker found in CJC-1295 DAC, it does not covalently bind to serum albumin. This results in a short terminal elimination half-life (approximately 30 minutes in animal models), mimicking natural endogenous GH pulses rather than inducing continuous receptor occupation.
Research in animal models suggests that this pulsatile signaling profile maintains physiological receptor sensitivity without downregulating somatotrope responsiveness over multi-week experimental windows. Investigators study these mechanisms primarily in relation to cellular regeneration, muscle protein synthesis assays, connective tissue remodeling, and lipid metabolism pathways.
Furthermore, tissue repair models utilize the dual GHRH/GHS-R1a agonist architecture to measure collagen deposition and osteoblast activity. By tracking biomarker surges, laboratory teams gather baseline data on how controlled growth hormone amplification affects nitrogen retention and localized tissue repair in vitro.
Understanding the price variance between commercial suppliers requires examining the multi-stage chemical synthesis and verification protocols required for research-grade materials. Lower price points often indicate skipped purification stages, crude peptide mixtures, or unverified off-shore toll manufacturing.
Key cost parameters in manufacturing high-grade CJC-1295 (No DAC) and Ipamorelin include:
1. Solid-Phase Peptide Synthesis (SPPS): The step-by-step assembly of amino acid sequences requires high-purity reagents, protection chemistry, and specialized automated synthesizer systems to prevent truncation sequences. 2. Multi-Stage RP-HPLC Purification: High-Performance Liquid Chromatography separates correct full-length peptide sequences from synthesis side-products. Achieving purity targets exceeding 98% requires multiple chromatographic passes, increasing solvent and matrix expenditure. 3. Lyophilization and De-salting: Converting the liquid eluate into a stable, dry lyophilized cake requires specialized freeze-drying cycles under sterile vacuum conditions to maintain peptide tertiary structure and prevent degradation. 4. Endotoxin Removal: Preclinical cell cultures and sensitive animal protocols require strict bacterial endotoxin limits (<0.5 EU/mg). Advanced membrane filtration and Limulus Amebocyte Lysate (LAL) testing add significant baseline costs to batch manufacturing.
Investigating these parameters demonstrates why purchasing validated materials from an established supplier like PX1 Research ensures consistent experimental conditions, avoiding the financial cost of corrupted trial data.
In growth hormone secretagogue research, scientists compare several peptide architectures to evaluate receptor kinetics, half-life parameters, and downstream signaling pathways. Selecting the ideal target complex depends entirely on whether continuous exposure or transient pulsatile signaling is desired in the experimental design.
Compared to long-acting variants like CJC-1295 DAC, which maintains elevated serum GH levels for days, CJC-1295 (No DAC) offers rapid clearance that isolates discrete physiological pulses. When baseline GHRH activation is required alongside ghrelin mimetic action, alternative single-agent GHRH analogs like Sermorelin or Tesamorelin may be evaluated. However, combining Mod GRF 1-29 with selective GHRPs like Ipamorelin or legacy secretagogues like GHRP-2 yields higher peak growth hormone amplitude in preclinical assays due to cross-talk between the G Protein-Coupled Receptors (GPCRs) involved.
A reliable Certificate of Analysis (COA) provides quantitative proof of product composition and purity. When reviewing vendor credentials, research institutions must demand lot-specific third-party COAs rather than generic in-house statements.
A compliant analytical dossier includes clear HPLC chromatograms confirming a purity rating of 98% or higher, alongside electrospray ionization mass spectrometry (ESI-MS) spectra proving exact molecular weight. For CJC-1295 (No DAC), MS verification confirms the predicted monoisotopic mass of 3367.9 Da, while Ipamorelin reflects its target mass of 711.9 Da.
Additionally, verifying low microbial and endotoxin levels protects target cell cultures from baseline inflammatory artifacts. PX1 Research mandates third-party batch testing conducted by accredited ISO 17025 laboratories, publishing batch records directly within our public research documentation repository.
Proper handling of lyophilized peptide complexes ensures structural stability and prevents premature enzymatic degradation during experimental trials. Reconstitution procedures must adhere to strict aseptic techniques within a certified laminar flow hood.
Bacteriostatic Water (0.9% benzyl alcohol) or sterile water for injection is typically introduced slowly down the interior glass wall of the vial to minimize shear stress on the peptide matrix. Swirling the vial gently facilitates dissolution; vigorous shaking or high-speed vortexing should be strictly avoided as physical agitation can cause peptide aggregation and loss of biological activity.
For specific protocol planning, concentration calculations, and solvent compatibility matrices, researchers can consult our dedicated peptide reconstitution guide.
Lyophilized CJC-1295 (No DAC) and Ipamorelin dual-vials exhibit high stability when stored under desiccation at -20°C or -80°C, remaining viable for up to 24 months. Short-term exposure to ambient temperatures during transit does not degrade high-purity lyophilized cakes, provided vials are immediately returned to cold storage upon receipt.
Once reconstituted into aqueous solution, the peptide complex is susceptible to hydrolysis and oxidation. Reconstituted solutions should be stored at 2°C to 8°C and utilized within 21 to 30 days. To avoid repetitive freeze-thaw cycles—which degrade peptide chains—researchers should aliquot single-use working volumes into sterile microcentrifuge tubes prior to deep freezing.
Acquiring reliable research peptides requires a supplier committed to batch integrity, rapid fulfillment, and complete analytical transparency. PX1 Research operates GMP-compliant processing facilities within the United States, utilizing rigorous quality control systems to ensure identical lot-to-lot performance.
All products are shipped directly from California and Arizona distribution hubs with same-day dispatch for orders placed before daily cutoff times. Institutional procurement divisions seeking volume pricing or dedicated lab accounts can explore our structured purchasing programs directly through the PX1 Research catalog.
What factors determine the research price of CJC-1295 Ipamorelin No DAC?
Pricing is governed by solid-phase synthesis costs, multi-step RP-HPLC purification to achieve >98% purity, mass spectrometry sequence confirmation, microbial/endotoxin assay testing, and freeze-drying quality control.
What is the structural difference between CJC-1295 No DAC and CJC-1295 with DAC?
CJC-1295 No DAC (Mod GRF 1-29) lacks the Drug Affinity Complex (DAC) maleimido-propionic acid reactive linker. Consequently, it does not bind to serum albumin, resulting in a 30-minute half-life that mimics natural pulsatile GH release, whereas CJC-1295 DAC exhibits a half-life of several days.
Why are CJC-1295 No DAC and Ipamorelin co-administered in preclinical studies?
In vitro and animal models demonstrate that combining a GHRH agonist (CJC-1295 No DAC) with a selective ghrelin receptor agonist (Ipamorelin) produces synergistic GH secretion by simultaneously activating distinct signaling pathways on pituitary somatotropes.
How should lyophilized CJC-1295 Ipamorelin No DAC be stored upon delivery?
Lyophilized vials should be stored at -20°C or -80°C in a desiccated environment for long-term storage. Vials can remain stable at refrigerated temperatures (2°C to 8°C) for short-term handling.
What is the stability of reconstituted CJC-1295 Ipamorelin No DAC?
Once reconstituted with bacteriostatic water, liquid solutions should be kept refrigerated at 2°C to 8°C and used within 21 to 30 days. Multiple freeze-thaw cycles should be avoided by creating small single-use aliquots.
How does PX1 Research verify peptide batch purity?
Every lot undergoes independent third-party analytical testing, including Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) for purity assessment and Mass Spectrometry (MS) for molecular weight confirmation.
What endotoxin limits are enforced for PX1 Research compounds?
PX1 Research compounds undergo LAL testing to ensure bacterial endotoxin levels remain below strictly defined laboratory limits (<0.5 EU/mg), making them suitable for cell culture and preclinical assays.
Are CJC-1295 and Ipamorelin compounds cleared for human clinical consumption?
No. All products supplied by PX1 Research are strictly designated for laboratory in vitro and preclinical research applications. They are not intended for human or animal diagnostic, therapeutic, or clinical use.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.